Astrin Biosciences
PrivateLast Round
VC Round
Jun 11, 2024
Total Funding Raised
$399,678
Company Overview
Astrin Biosciences operates in Healthcare & Life Sciences and is based in Saint Paul, Minnesota. Its latest recorded funding round was a VC Round in June 2024.
Astrin Biosciences is a biotechnology company that develops diagnostic tools designed for early cancer detection and precision therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Astrin Biosciences Comparables
Compare Astrin Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mammogen | 89% | |
| Syantra Inc. | 87% | |
| Bcal Diagnostics Ltd | 77% |
For institutional investors. Book with your work email.
Astrin Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 11, 2024 | ||||
| Grant | Jun 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Astrin Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
New board will support AI-enabled proteomics platform development.
- Dec 1, 2025
Developing an AI-enabled proteomics platform for early cancer detection.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 9, 2026
On Oct 9th '26, Astrin and OpenLoop Health, Inc. partner to expand telehealth access to a supplemental breast cancer blood test across 48 states.
- launchesSep 29, 2026
Astrin announced in Minnesota on Sep 29th '26 that its Certitude(TM) blood-based, non-imaging supplemental breast cancer screening test is now available to eligible women across 48 states through OpenLoop Health's digital platform.
- hiresSep 16, 2026
On Sep 16th '26 in Minnesota, Astrin appointed Dr. Tanya Gupta as Medical Director, bringing breast oncology expertise as the company scales Certitude(TM) Breast.
For institutional investors. Book with your work email.
Astrin Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Astrin Biosciences's valuation, stock price, and market status.
Is Astrin Biosciences a public or private company?
Astrin Biosciences is a private company.
What is the current stock price of Astrin Biosciences?
Astrin Biosciences is a private company, so its shares have no public market price. Caplight tracks Astrin Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Astrin Biosciences worth (valuation)?
Valuation information for Astrin Biosciences is not publicly available.
Can I buy Astrin Biosciences stock?
Astrin Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Astrin Biosciences's last funding round?
Astrin Biosciences's most recent funding round was VC Round on June 11, 2024.
Who are the main investors in Astrin Biosciences?
Key investors in Astrin Biosciences include National Cancer Institute.
Will Astrin Biosciences IPO soon?
No public IPO plans have been announced for Astrin Biosciences.
How can I track Astrin Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Astrin Biosciences's shares on secondary markets.